165948-23-2

Basic information

• Product Name: 4,5,6,7-TETRAHYDRO-THIAZOLO[5,4-C]PYRIDINE HYDROCHLORIDE SALT
• Synonyms: 4,5,6,7-TETRAHYDRO-THIAZOLO[5,4-C]PYRIDINE HYDROCHLORIDE SALT;4,5,6,7-Tetrahydrothiazolo[5,4-c]pyridine hydrochloride;4,5,6,7-TETRAHYDRO[1,3]THIAZOLO[5,4-C]PYRIDINE;4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine;Thiazolo[5,4-c]pyridine,4,5,6,7-tetrahydro-;4,5,6,7-Teterahydrothiazolo[5,4-c]pyridine
• CAS NO: 165948-23-2
• Molecular Formula: C6H9ClN2S
• Molecular Weight: 176.66706
• Mol File: 165948-23-2.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 367 °C at 760 mmHg
• Flash Point: 175.7 °C
• Appearance: /
• Density: 1.219±0.06 g/cm3(Predicted)
• PKA: 7.88±0.20(Predicted)
• CAS DataBase Reference: 4,5,6,7-TETRAHYDRO-THIAZOLO[5,4-C]PYRIDINE HYDROCHLORIDE SALT(CAS DataBase Reference)
• NIST Chemistry Reference: 4,5,6,7-TETRAHYDRO-THIAZOLO[5,4-C]PYRIDINE HYDROCHLORIDE SALT(165948-23-2)
• EPA Substance Registry System: 4,5,6,7-TETRAHYDRO-THIAZOLO[5,4-C]PYRIDINE HYDROCHLORIDE SALT(165948-23-2)

Safety Data

• Hazardous Substances Data: 165948-23-2(Hazardous Substances Data)

Usage

General Description

4,5,6,7-Tetrahydro-thiazolo[5,4-c]pyridine hydrochloride salt is a chemical compound that consists of a thiazolo-pyridine ring system with a tetrahydro group. It is typically found in the form of a hydrochloride salt. 4,5,6,7-TETRAHYDRO-THIAZOLO[5,4-C]PYRIDINE HYDROCHLORIDE SALT is used in the pharmaceutical industry for its potential medicinal properties, such as its ability to act as an antagonist or agonist at certain receptor sites in the body. It may also have applications in the field of organic synthesis and chemical research. The chemical structure of 4,5,6,7-Tetrahydro-thiazolo[5,4-c]pyridine hydrochloride salt makes it an interesting target for further study and potential drug development.

InChI:InChI=1/C6H8N2S.ClH/c1-2-7-3-6-5(1)8-4-9-6;/h4,7H,1-3H2;1H

Upstream product

• 165948-22-1 5-Ethoxycarbonyl-4,5,6,7-tetrahydrothiazolo[5,4-c]-pyridine 
• 89424-04-4 3-chloro-1-ethoxycarbonyl-4-piperidone 
• 79099-07-3 N-tert-butyloxycarbonylpiperidin-4-one 
• 188869-05-8 tert-butyl 3-bromo-4-oxo-piperidine-1-carboxylate 
• 365996-05-0 tert-butyl 2-amino-6,7-dihydrothiazolo[5,4-c]pyridine-5(4H)-carboxylate 
• 365996-06-1 2-Bromo-5-tert-butoxycarbonyl-4,5,6,7-tetrahydro-thiazolo[5,4-c]pyridine 
• 165948-24-3 5-tert-Butoxycarbonyl-4,5,6,7-tetrahydrothiazolo[5,4-c]-pyridine 

Downstream Products

• 165948-24-3 5-tert-Butoxycarbonyl-4,5,6,7-tetrahydrothiazolo[5,4-c]-pyridine 
• 758685-72-2 5-methyl-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridine-2-carboxylic acid 

Relevant articles and documents

Substituted oxazolidinone compounds and method and use thereof

The invention provides a substituted oxazolidinone compound represented by a formula (I) shown in specifications, or stereoisomers, tautomers, nitrogen oxides, solvates, metabolites and pharmaceutically acceptable salts or prodrugs thereof. The compound i

Orally active factor Xa inhibitors: 4,5,6,7-tetrahydrothiazolo[5,4-c] pyridine derivatives

In our investigation of factor Xa inhibitors, a series of 1-(6-chloronaphthalen-2-yl)sulfonyl-4-(4,5,6,7-tetrahydrothiazolo[5,4-c] pyridine-2-carbonyl)piperazines 3a-i were synthesized. In vitro inhibitory activities of the compounds against factor Xa and coagulation are summarized. Among the compounds, 3c and 3d, possessing a carbamoyl or N-methylcarbamoyl moiety, showed potent inhibitory activities when administered orally to rats.

Compound with platelet aggregation inhibitor activity

A compound represented by the general formula (I) and a pharmaceutically acceptable salt and solvate thereof having an effect for inhibiting the agglutination of platelets is disclosed: STR1 wherein R1 represents a group --W--(CH2)i --COOR3, R2 represents a hydrogen atom or a group --W--(CH2)i --COOR3 or --OR4, X represents --CH= or --N=, Y represents (i) a group --(CO)k --N(R5)--Z--, wherein Z represents a bond or a group --(CH2)m --CO-- or a group --(CH2)m --CHR6 --, (ii) a group --(CH2)m --N(R5)--(CO)k --, or (iii) a group --(CO)k -Het, wherein Het represents a five- or six-membered heterocyclic ring comprising a nitrogen atom, A represents (i) the following groups (III) or (IV) STR2 B represents a bond, C1-6 alkylene or C2-6 alkenylen.